The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
Severe mpox and long-term sequelae such as severe scarring were more likely to occur among HIV-positive patients with detectable viral loads and low CD4 counts.
The pandemic served as a boot camp for Rhode Island public health officials and infectious diseases doctors, preparing them for future health crises ...
A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.
Universiti Putra Malaysia consultant clinical microbiologist Prof Dr Zamberi Sekawi said mpox is transmitted by close direct contact and is of lower risk compared with airborne transfers.
Health officials have raised alarms over a newly identified, highly transmissible mpox variant, suspected of driving a surge ...
The results from STOMP reinforce the value of randomized clinical trials during outbreaks of infectious diseases, like mpox,” said Past ACTG Chair Judith Currier M.D., M.Sc. “There was considerable ...
Uganda is set to receive 100,000 doses of the Mpox vaccine to administer booster shots to those previously vaccinated, as well as high-risk individuals. This comes as the country continues ...
The first Mpox case in Nakasongola District was reported on September 9, 2024, in Zengebe Village, Lwampanga Town Council, ...
NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results